Searched for
CONCORD BIOTECH LISTING
Forget the noise: These 54 smallcap stocks attracted FII buying in March quarterForeign institutional investors are strategically buying into beaten-down smallcap stocks in India, increasing stakes in 54 companies despi...- Top individual investors see mixed fortunes in December quarterIndia's top investors experienced mixed results in the December quarter. While some portfolios saw gains between 2% and 11%, others faced d...
- Most top Indian investors see drop in net worth in July–Sept quarterThe third quarter of the year brought unexpected changes to the fortunes of Indian investors. As the markets weakened, most wealthy individ...
- Patanjali Foods, Prestige Estates among 13 dividend stocks to watch: Last day to buyInvestors eyeing dividend payouts should note today is the last day to buy shares of Patanjali Foods and Prestige Estates Projects to quali...
- Concord Biotech stock slips over 5% after Rs 519 crore worth of shares change handsShares of Concord Biotech fell 5.3% on BSE due to a large block deal where Ontario Inc. sold a 3.4% stake at a discount, impacting stock pe...
- This smallcap mutual fund added 12 new stocks in February while exiting 7 othersBandhan Small Cap Fund-Reg(G) revamped its portfolio in February with new stock additions and exits. The scheme, benchmarked against S&P BS...
- For investors, Street still paved with goldGujarat Fluorochemicals, Ramkrishna Forgings, IDFC, and Welspun Corp are some of the top holdings of Akash Bhansali. Three of his stocks, A...
- Hot Stocks: Jefferies upgrades JSW Steel, Motilal Oswal sees over 20% upside in Lemon TreeThe global investment bank maintained a buy rating on Coal India but raised the target price to Rs 450 from Rs 425 earlier.
- Top-performing fund turns to IPOs as India stocks turn priceyThe $1.2 billion Franklin India Smaller Companies Fund is up 34% this year, beating 98% of its peers. The fund’s IPO picks — Concord Biotec...
- Concord Biotech's niche strengths seen buoying earnings: AnalystsShares of the Ahmedabad-based biopharma company, which listed a few weeks ago at a more than 20% premium, have notched another 9% gain sinc...
- Concord Biotech shares list at a healthy premium. What should investors do?Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Concord Biotech shares list at 21% premium over IPO priceConcord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Stocks in news: Nykaa, HDFC AMC, Concord Biotech, JSW Steel, Adani EnergyNykaa, HDFC AMC, Indus Towers, Page Industries and ACC have been excluded from Nifty Next50 in the latest revision of various NSE indices.
- Concord Biotech to list on Friday. Here’s what GMP suggestsAnalysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which ...
- Concord Biotech IPO share allotment likely today. Here's how you can check statusOn the allotment date, investors get to know about the number of shares allotted to them as against the bids made. They can check the allot...
- Another Jhunjhunwala long bet blooms with Concord Biotech offerThe ace investor often called India's Warren Buffet, first invested in Concord in 2004 and later helped the company's founder in buying bac...
- SBFC Finance vs Concord Biotech: Which IPO should you pick?The issue of SBFC Finance comprises fresh equity issue of Rs 600 crore and an offer for sale (OFS) of Rs 425 crore, while Concord Biotech i...
- SBFC Finance and 4 other IPOs set to hit the Street this week. Check detailsThe next week is set to be busy for Dalal Street with five IPOs, including both main board and SME, to hit primary markets. SBFC Finance's ...
- Concord Biotech, Vaibhav Gems get Sebi's approval to float IPOsThe company is backed by Quadria Capital Fund and Rare Enterprises, which was set up by billionaire investor Rakesh Jhunjhunwala, along wit...
- Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with SebiAs per an F&S report, Concord Biotech commands a market share of over 20 per cent by volume in 2021 across identified fermentation-based AP...
Load More
